Security key
04216R102
Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP)
CUSIP: 04216R102
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock, $0.01 par value
- Total 13F shares
- 740,370
- Total 13F value
- $1,080,988
- Share change
- -648,456
- Put/Call ratio
- 333%
- SEC-reported price per share
- $1.46
- Number of holders
- 25
- Value change
- -$948,245
- Number of buys
- 4
- Number of sells
- 9
- Shares outstanding
- 67,070,688
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
25
Top holders
10
ARMP full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Armata Pharmaceuticals, Inc. SEC filings
Armata Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 04216R102
Recent filing periods:
Ownership snapshot
Top reported holders of ARMP - Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BANK OF AMERICA CORP /DE/
Disclosed value leader
BANK OF AMERICA CORP /DE/
Comparable rows
15/15
Latest evidence
31 Dec 2024
13F
Lead comparable stake: 0.95%
Showing 1-6 of 15 holder rows.
Quick read
BANK OF AMERICA CORP /DE/ leads the comparable SEC ownership view at 0.95%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BANK OF AMERICA CORP /DE/'s linked filing trail.
Comparable ownership
Top 5
BANK OF AMERICA CORP /DE/
0.95%
VANGUARD GROUP INC
0.35%
GEODE CAPITAL MANAGEMENT, LLC
0.16%
EDGEWOOD MANAGEMENT LLC
0.15%
BRIDGEWAY CAPITAL MANAGEMENT, LLC
0.1%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
0.95%
|
$1,172,959
634,032 shares
|
— | 31 Dec 2024 |
| VANGUARD GROUP INC |
13F
Company
|
0.35%
|
$433,120
234,119 shares
|
— | 31 Dec 2024 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.16%
|
$197,622
106,789 shares
|
— | 31 Dec 2024 |
| EDGEWOOD MANAGEMENT LLC |
13F
Company
|
0.15%
|
$185,000
100,000 shares
|
— | 31 Dec 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
Company
|
0.1%
|
$128,912
69,682 shares
|
— | 31 Dec 2024 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
Company
|
0.07%
|
$92,108
49,788 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
25
Shares
740,370
Rows available
25
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2026 Across Filers
Q1 2026 holders
44
Q1 2025 holders
25
Holder diff
-19
| Investor | Q1 2026 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend